Towa Pharmaceutical Co (JP:4553) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Towa Pharmaceutical Co., Ltd. has reached a settlement in a patent infringement lawsuit filed by Eagle Pharmaceuticals, Inc. and SymBio Pharmaceuticals Limited concerning two of its intravenous infusion products. The lawsuit, initiated in December 2022, has been resolved with undisclosed terms, and Towa Pharmaceutical will continue to manufacture and sell the products with minimal impact on its consolidated financial results.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.